A.R.T. Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-2,698
Closed -$231K – 61
2020
Q4
$231K Buy
+2,698
New +$223K 1.07% 44
2020
Q3
– Sell
-6,198
Closed -$454K – 106
2020
Q2
$454K Buy
+6,198
New +$440K 0.68% 29
2018
Q2
– Sell
-12,100
Closed -$867K – 1462
2018
Q1
$867K Buy
12,100
+5,100
+73% +$367K 0.03% 721
2017
Q4
$528K Sell
7,000
-52,900
-88% -$3.86M 0.02% 874
2017
Q3
$4.36M Buy
59,900
+19,900
+50% +$1.43M 0.22% 102
2017
Q2
$2.96M Buy
+40,000
New +$2.97M 0.16% 158
2017
Q1
– Sell
-26,700
Closed -$1.75M – 1454
2016
Q4
$1.75M Buy
26,700
+12,900
+93% +$884K 0.1% 308
2016
Q3
$1.02M Sell
13,800
-25,751
-65% -$1.9M 0.33% 68
2016
Q2
$2.9M Buy
+39,551
New +$2.82M 0.14% 197

Other funds holding CL

A.R.T. Advisors's CL Position: Q1 2021 in Review

A.R.T. Advisors sold out of Colgate-Palmolive (CL) in Q1 2021, closing a stake of 2,698 shares — an estimated $231K sold.

A.R.T. Advisors first reported a position in CL in Q2 2016 and held it in 9 quarters. The position peaked at $4.36M in Q3 2017. 1,609 funds tracked by Wall St. Rank hold CL as of Q1 2021.

  • A.R.T. Advisors reported no remaining Colgate-Palmolive position as of Q1 2021 after selling out during the quarter.
  • A.R.T. Advisors sold 2,698 Colgate-Palmolive shares in Q1 2021, an estimated $231K.
  • A.R.T. Advisors first reported a position in Colgate-Palmolive in Q2 2016 and held it in 9 quarters.
  • A.R.T. Advisors's Colgate-Palmolive position peaked at $4.36M in Q3 2017.
  • 1,609 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on A.R.T. Advisors's 13F filing for Q1 2021, filed 17 May 2021.